Kadefemin Estriol Ovula 0.03 mg, Ovula

7680671700015 CH-67170 Suppositorien

Associated product:

KADEFEMINE Estriol ovule 0.03 mg 20 pce
Kadefemin Estriol Ovula 0.03 mg, Ovula
Kadefemin Estriol Ovula 0.03 mg, Ovula
Kadefemin Estriol Ovula 0.03 mg, Ovula
1 / 3
google

Article details

Package size
20
Selling units
20
Measure
Suppositorien
Galenic form
Suppositorien
Galenic group
Suppositorien

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
04/04/2025
Patient information leaflet
Français
04/04/2025
Patient information leaflet
Italien
04/04/2025
Summary of Product Characteristics
Allemand
04/04/2025
Summary of Product Characteristics
Français
04/04/2025
Summary of Product Characteristics
Italien
04/04/2025

Detailed composition

Substance Quantity Type Category
B
0.03 MG Substance Wirkstoff (Principe actif)
B
- Substance ANTOX

Authorization holder

Zeller Medical AG

8590 Romanshorn

Authorization information

Swissmedic authorization number
67170
Drug name
Kadefemin Estriol Ovula 0.03 mg, Ovula
Galenic form
VAGZ
ATC Code
G03CA04
Authorization status
Z
Dispensing category
B
First authorization
02/05/2019
Authorization expiration date
31/12/9999
IT Number
07.08.2.
Domain
Human medicine
Field of application
Vaginale Oestrogensubstitutionstherapie

Package details

Description (FR)
KADEFEMINE Estriol ovule 0.03 mg 20 pce
Description (DE)
KADEFEMIN Estriol Ovula 0.03 mg 20 Stk
Market launch
02/05/2019
Narcotic (BTM)
No